Target intelligence / Profile preview

Glycerophospholipid metabolism enzyme (null)

Target
null
Molecular classification
Enzyme
01

Overview

Glycerophospholipid metabolism enzymes are a diverse group of enzymes that catalyze the synthesis, remodeling, and degradation of glycerophospholipids—the major structural lipids of eukaryotic cellular membranes[6][1]. Key enzyme classes include acyltransferases (such as G3PAT, AGPAT), phospholipases (e.g., PLA2), kinases, and phosphatases[4][6]. These enzymes mediate multiple steps: the sequential acylation of glycerol-3-phosphate, head-group addition, remodeling of fatty acid chains, and breakdown of glycerophospholipids. The activity of these enzymes influences membrane composition, cellular signaling (for instance, by generating second messengers like DAG and IP3), and cellular functions such as growth, division, apoptosis, and responses to stress. Dysregulation of glycerophospholipid metabolism enzymes has been implicated in diseases such as cancer, cardiovascular disease, neurodegeneration, and inflammation, due to their role in cell proliferation, survival, and signaling[2][7]. Note: “Glycerophospholipid metabolism enzymes” is a functional category, not a unique molecular target—it includes many distinct enzymes, each encoded by separate genes and with potentially unique therapeutic relevance[4]. To obtain structured target data, further specificity (i.e., selecting a particular enzyme such as “Phospholipase A2” or “Lysophosphatidylcholine acyltransferase”) is necessary.

Other names
Glycerophospholipid metabolic enzymeGlycerophospholipid-metabolizing enzymeGlycerophospholipid metabolic pathway enzyme
02

Mechanism of action

null

03

Biological functions

Lipid metabolismMembrane remodelingSignal transductionEnergy metabolismGeneration of lipid mediators
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseInflammationOther
05

Safety considerations

Enzyme redundancy complicates targeting specificityEssential housekeeping function increases risk of toxicity

Beyond the preview

Go deeper on Glycerophospholipid metabolism enzyme (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glycerophospholipid metabolism enzyme (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call